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Role of Balloon Guide Catheter in Modern Endovascular 
Thrombectomy
Ju-Yu Chueh,1,* Dong-Hun Kang,2,* Byung Moon Kim,3 Matthew J. Gounis1
Department of Radiology,1 New England Center for Stroke Research, University of Massachusetts Medical School, Worcester, MA, USA 
Department of Neurosurgery and Radiology,2 School of Medicine, Kyungpook National University, Daegu, Korea 
Department of Radiology,3 Severance Stroke Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
Proximal flow control achieved with a balloon guide catheter (BGC) during endovascular treatment of acute ischemic stroke is 
reviewed in this article. In clinical practice, BGCs offer a multi-faceted approach for clot retrieval by creating proximal flow arrest, 
reducing embolic burden, and shortening procedure time. Evaluation of frontline thrombectomy procedures with BGCs revealed 
advantages of combined use over the conventional guide catheter (CGC), notably in the significant reduction of distal emboli 
to both the affected and previously unaffected territories. Recently, new measures of early and complete reperfusion at first 
thrombectomy pass have been identified as independent predictors of improved outcomes, which were consistently demonstrated 
with use of BGC as a safe and effective option to minimize number of passes during intervention. Prior randomized controlled trials 
reported the positive correlation between BGC-treated patients and a lower risk of mortality as well as shortened procedure time. 
While BGC use is more common in stent retriever-mediated mechanical thrombectomy, preliminary data has shown the potential 
benefit of device application during contact aspiration thrombectomy to achieve successful recanalization. However, the question 
of which major endovascular strategy reigns superior as a frontline remains to be answered. Along with clinical case assessments, 
BGC performance during in-vitro simulation was analyzed to further understand mechanisms for optimization of thrombectomy 
technique.
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INTRODUCTION
Rapid evolution in endovascular management of acute large 
vessel occlusion (LVO) over the past 20 years has enabled neu-
rointerventionalists to offer effective reperfusion treatments 
to properly selected patients. Evolving endovascular tech-
niques for use in cases of acute LVO include intra-arterial fi-
brinolysis, ultrasound-enhanced fibrinolysis, retrievers, con-
tact aspiration with (and later without) catheter debulking 
separators, and stent-retrievers50,56). Recently, stent retriever-
mediated mechanical thrombectomy (SR-MT) is considered 
the standard-of-care for selected patients with acute LVO in 
the anterior circulation due to positive results of recent five 
randomized clinical trials (RCT)2,4,16,22,52). A Direct Aspiration 
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First Pass Technique (ADAPT) or contact aspiration throm-
bectomy (CAT) using large bore catheters is also employed as 
another frontline treatment for LVO12,24,32). During the evolu-
tion of thrombectomy strategies, the versatile uses of 8 F or 9 
F balloon guide catheters (BGC) in different clinical setups 
have been recognized as BGCs can be paired with a single clot 
retriever system23,48) or combined with other adjunctive 
thrombectomy procedures15,37,39). 
Clot fragmentation is an inevitable consequence of me-
chanical thrombectomy. Although fragments are generated 
throughout the procedure, the largest single contributor to 
distal emboli during SR-MT is associated with bringing the 
device and embedded clot into a receiver, namely a catheter. 
Since the majority of the clot remains on the outside of the de-
vice63), the clot is sheared off the device as it enters the receiver. 
Inflation of the BGC causes a momentary blockage of ante-
grade blood f low during SR-MT. Direct aspiration through 
the BGC during retrieval, or simply removing the rotating he-
mostatic valve while withdrawing the SR leads to flow reversal 
at the tip of the BGC allowing the sheared fragments to be re-
moved from the circulation. Regarding the use of BGC during 
ADAPT, there is a concern about the compromised efficacy of 
aspiration due to the limitation of the size of aspiration cathe-
ter that can be used with the limited inner diameter of the 
BGC. However, in real practice, some neurointerventionalists 
have used BGC during ADAPT and have reported the positive 
role of BGC compared to CGCs25,57). In addition to lowering 
the risk of distal embolization, shorter procedure time and 
higher rate of first-pass success as well as better clinical out-
comes are further benefits of using BGCs versus non-BGCs, 
which will be discussed later in this paper40,44,64,69).
Potential off-label use of BGCs has been described in the 
previous clinical cases11,49). Direct aspiration from the cervical 
internal carotid artery (ICA) through BGC without any other 
aspiration catheter or stent retriever was found to be effective 
in removing or reducing extensive clot burden such as termi-
nal carotid T- and L-type occlusions. Although the feasibility 
of this technique may be limited due to the complexity of the 
clot characteristics, blood supply from communicating arter-
ies, and the tortuosity of the vasculature, successful BGC aspi-
ration in eligible patients is likely to reduce the large clot bur-
den in a short period of time and allow smooth transition to 
the subsequent treatment option such as SR-MT. Lastly, for 
patients with severe carotid stenosis, temporary inflation of a 
BGC is helpful for endovascular device delivery, particularly 
for a distal access catheter to enter a proximal ICA stent lu-
men as illustrated in a previous case10). 
Many neurointerventionalists have been reluctant to use 
BGCs due to a number of concerns, such as difficulty in han-
dling the device, groin complications in patients who are on 
anticoagulant drugs, induced occlusion of the feeding artery 
by the BGCs, and compatibility of BGCs with other devic-
es47,54). A recent study retrospectively evaluated the risk of 
groin complications associated with the use of a large bore 
BGC or sheath in 472 LVO patients who received mechanical 
thrombectomy54). The results suggested that the rate of large 
bore sheath-related groin complications was between 0.4% to 
0.8% and such minimal risk should not dissuade neurointer-
ventionalists from using BGCs.
EVALUATION OF BALLOON GUIDE CATHETER IN 
EXPERIMENTAL MODELS 
Successful development of in-vitro occlusion models not 
only makes reproducible simulation of mechanical thrombec-
tomy possible but also provides deeper insight into how cur-
rent thrombectomy technology can be refined to obtain better 
clinical outcomes. Measures such as device deliverability, re-
canalization success, hemodynamic data, and distal emboli-
zation can be collected and quantified during the in-vitro 
BGC-related studies.
The key elements of an in-vitro model system of cerebrovas-
cular occlusion include a patient-specific vascular phantom 
with collateral circulation, engineered clot analogues, and a 
flow loop7,14,42,43). Different manufacturing processes for neuro-
vascular modeling have been described in previous work9,31,53). 
The silicone elastomer is often selected as a base material for 
constructing vascular replicas due to its high transparency and 
the similar stress-strain relationship to the human cerebral ves-
sel from postmortem examination at low stretch9). The trans-
parent silicone vascular replica and radiopaque clots allow visu-
alization of clot-device interaction during mechanical 
thrombectomy. For example, clot shear-off from the stent re-
triever was observed previously in both the in-vitro (Fig. 1) and 
in-vivo studies during the BGC assisted SR-MT when the stent 
retriever was retracted17). Parts of the clot were found dislodged 
and accumulated at the tip of the BGC, compromising the BGC 
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aspiration efficacy. Identifying such a problem preclinically can 
help improve the thrombectomy technique and reduce the risk 
of distal embolization.
Occurrence of embolic shower is one of the undesirable ef-
fects of the SR-MT and is technically modifiable. A study with 
a total of 144 LVO patients enrolled between 2009 and 2011 
reported that embolic events happened in 12.5% (18/144) of 
the patients who received SR-MT and were associated with a 
higher rate of mortality compared to those with no embolic 
complications13). Interestingly, the incidence of distal emboli 
or emboli in new territories seems lower in human studies 
compared to in-vitro bench studies. Detection of distal emboli 
in an in-vitro setup was achieved by Mokin et al.43) via gross 
observation and high-definition video recording. The results 
of Mokin’s study showed that the occurrence of embolization 
in new territories was significantly reduced by the BGCs, 
compared with CGCs (p=0.0057). However, the emboli size 
range analyzed in this study was not specified and there were 
no differences in number of emboli observed in distal territo-
ry between BGCs and CGCs (p=1.0).
Another approach for distal emboli characterization was 
performed by using the Coulter Principle6-8). Saline was circu-
lating in an middle cerebral artery (MCA) occlusion model, 
and effluent from both the MCA and anterior cerebral artery 
(ACA) was collected during the thrombectomy procedure for 
particle characterization. When a particle (clot fragment) trav-
eled through the aperture, change in the impedance across the 
aperture was measured. The pulse height was proportional to 
the volume of the sensed particle and was converted to an 
equivalent spherical diameter. Completion of the particle 
analysis yielded not only the number, but the size of each clot 
fragment within the 8–1000 µm range. For particles sized 
D FE
A CB
Fig. 1. In-vitro observation of clot shear-off from a stent retriever during mechanical thrombectomy. A : A stent retriever is deployed at the MCA to capture the 
clot (blue arrow). B-E : Prior to clot retrieval, the balloon is inflated (red star) to arrest the ICA flow. Clot fragmentation is observed during clot removal (blue arrows) 
with the balloon inflated (red star). F : Clot shear-off from a stent retriever is noted, resulting in a portion of the clot remaining (blue arrow) at the tip of the BGC (red 
star). MCA : middle cerebral artery, ICA : internal carotid artery, BGC : balloon guide catheter.
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greater than 1 mm, a caliper was used to measure the maxi-
mum length of each particle. Prior in-vitro studies using the 
Coulter Principle for clot measurements found that BGCs sig-
nificantly reduced the formation of distal emboli when com-
pared to the CGCs6), and the BGC-protected thrombectomy 
was similar to SR-MT with the Lazarus Cover device 
(Medtronic Neurovascular, Irvine, CA, USA) in terms of the 
risk of distal embolization7). An important finding from these 
in-vitro studies was that the majority of the emboli generated 
during SR-MT are <20 µm. To date, brain tolerance to emboli 
is little known; therefore, the ischemic brain damage related to 
these small particles is difficult to predict. Further investiga-
tion through appropriate selection of animal models and ad-
vanced imaging techniques should be considered to address 
the aforementioned issue.
Blood flow control in the cervical ICA has a great impact on 
the risk of distal or new territory embolization during SR-MT. 
Quantification of f low reversal and arrest during balloon in-
flation have been studied in the in-vitro MCA occlusion mod-
els. The quantitative results demonstrate that MCA f low is 
partially restored (Fig. 2A and B, 73.3 mL/min vs. baseline 
flow of 134.6 mL/min) after deployment of the stent retriever. 
The presence of the collateral f low keeps the MCA flow con-
stant at 77.9 mL/min after BGC inf lation (Fig. 2C). During 
clot retrieval with the balloon inflated, instantaneous pressure 
changes are recorded at both proximal and distal ends of the 
clot (Fig. 2D). A recent study further suggested that when 
BGC is used in combination with large bore aspiration cathe-
ters, the efficacy of proximal aspiration via BGC is mini-
mized. As a result, the f low arrest in the ICA can cause re-
versed f low from the A1 or posterior communicating artery 
and can to antegrade flow in the M1 segment38).
Most of the experimental models for evaluation of mechan-
ical thrombectomy are embolic occlusion models with a single 
site of occlusion (e.g., MCA occlusion). Vasospasm, clot-vessel 
wall interaction as well as various underlying diseases in LVO 
patients, such as intracranial atherosclerosis, are not incorpo-
rated into the in-vitro neurovascular modeling. The absence 
of the abovementioned pathological processes may explain the 
high recanalization rate observed during the in-vitro simula-
Fig. 2. Simulation of SR-MT in an in-vitro setup allows real-time measurements of MCA flow and pressure prior to clot introduction (A), after 
deployment of stent retriever (B), after balloon inflation (C), and during clot retrieval (D). ACA : anterior cerebral artery, SR-MT : stent retriever-mediated 
mechanical thrombectomy, MCA : middle cerebral artery.
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tion of SR-MT and these limitations may be taken into con-
sideration during data interpretation.
BALLOON GUIDE CATHETER IN STENT RE-
TRIEVER THROMBECTOMY
The North American Solitaire Stent Retriever Acute Stroke 
(NASA) and Trevo Stent-Retriever Acute Stroke (TRACK) 
registries are two independent post-marketing registries in the 
United States that assess the effectiveness and clinical outcome 
of SR-MT in a real-life setting41,44,68). SR-MT was performed in 
both registries as the frontline technique for vessel recanaliza-
tion, with the Solitaire stent retriever in NASA and the Trevo 
device in TRACK. BGC was inf lated during the SR-MT to 
temporarily stop the antegrade flow in the carotid artery, and 
a similar rate of BGC use was reported in both studies (NASA : 
44% vs. TRACK : 47%). The results of the NASA registry re-
vealed that in comparison to the non-BGC group, patients 
with BGC had shorter procedure time, less adjunctive therapy 
and better clinical outcome at 90 days. BGC was an indepen-
dent predictor of good clinical outcome, and this finding was 
also noted in the TRACK registry. Based on those results, the 
use of BGC had become recommended during SR-MT by the 
manufacturers of Solitaire stent and Trevo device. One sug-
gested explanation for better outcome with the use of BGC is 
ischemic conditioning45,55). It is the hypothesis that blockage of 
the antegrade carotid flow via BGC applies the ischemic stim-
ulus to the vascular bed, resulting in the release of neuropro-
tective agents that may protect the ischemic tissue and im-
prove the clinical outcome20). However, as previously reviewed, 
BGC protected thrombectomy reduces the number and size of 
distal emboli which may alone explain the clinical benefit.
A number of animal and benchtop studies reported that SR-
MT with BGC reduced the formation of distal emboli; howev-
er, surprisingly, there were no significant effects of the BGC 
use on distal emboli and emboli in new territory in the NASA 
registry44). A similar finding was noted by Ahn et al.1). Possible 
explanations for the discrepancy between the experimental 
and clinical observations include that 1) the micron-sized em-
boli observed in the in vitro studies are not detectable angio-
graphically and 2) publication bias and heterogeneity across 
the studies can bias the results1). As of today, there is still a 
continuing controversy about the use of BGC during mechan-
ical thrombectomy, as reflected in the limited number of cases 
where BGC is used (approximately 50% of stroke interven-
tions)3). A series of studies have been done with the aim to un-
derstand the effects of BGC on the technique and clinical out-
comes for patients who underwent SR-MT3,34,59,64). It was 
found that patients treated with BGCs had a shorter procedure 
time, lower number of thrombectomy attempts, lower rates of 
mortality and higher odds of first-pass recanalization as com-
pared to those treated without BGCs. Achieving a Thrombol-
ysis in Cerebral Infarction (TICI) score of 3 with single 
thrombectomy pass defines the goal to pursue for future de-
velopment of thrombectomy devices67). The first-pass effect, 
an independent predictor of good clinical outcome, has be-
come a new measure of successful mechanical thrombectomy.
Several innovative treatment strategies have been developed 
based on the combined thromboaspiration and SR-MT tech-
nique, such as ARTS, CAPTIVE, CASPER, PROTECTPLUS, 
and SAVE36-39,58). The concept of combining local aspiration 
with a stent retriever is to provide continuous and localized 
suction via a distal intermediate and aspiration catheter from 
the proximal end of the occlusion during SR-MT. The ratio-
nale of providing suction adjacent to the occlusion is to en-
hance the clot engagement within the stent retriever and with-
draw the clot fragments released during initial stent retriever 
deployment21). In brief, a long sheath or a BGC is placed with-
in the common carotid artery or ICA of the affected side. Sub-
sequently, a large bore aspiration catheter is navigated over a 
microguidewire (and sometimes a microcatheter) to the level 
of the occlusion. A stent retriever device, usually Trevo or Sol-
itaire FR, is deployed via a microcatheter. The microcatheter 
is removed before clot removal to increase cross sectional lu-
minal area and aspiration efficacy of the aspiration catheter46). 
Suction can be applied via manual aspiration using a 20 mL or 
60 mL syringe or an aspiration pump. The aspiration catheter 
serves as a conduit through which the stent retriever along 
with the clot is removed from the patient. FlowGate (Stryker, 
Fremont, CA, USA; OD : 8 F, ID : 0.084”), Cello (Medtronic, 
Irvine, CA, USA; OD : 9 F, ID : 0.085” and OD : 8 F, ID : 
0.075”), Optimo (Tokai, Tokyo, Japan; OD : 9 F , ID : 0.088”), 
6F Neuron Max (Penumbra, Alameda, CA, USA; OD : 8 F, ID : 
0.088”) and 6F Cook Shuttle Sheath (Cook Medical, Bloom-
ington, IN, USA; OD : 8 F, ID : 0.087”) are common ancillary 
catheters used with current aspiration catheters. Frequently 
used aspiration catheters include, but are not limited to, AXS 
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CatalystTM 6 (Stryker), Sofia® and Sofia® Plus (Microvention, 
Tustin, CA, USA) and Penumbra ACETM (Penumbra).
Slight variations in procedure exist between the ARTS, 
CAPTIVE, CASPER, PROTECTPLUS and SAVE techniques. 
One example is the proximal aspiration with the guide cathe-
ter proposed in the SAVE method. Another notable difference 
is that the BGC is used in the ARTS and PROTECTPLUS 
techniques, whereas the large guiding sheath is recommended 
for the CAPTIVE, CASPER and SAVE techniques. It should 
be addressed that limited use of BGC may be due to the size 
incompatibility between BGCs and the principal chosen tech-
nique5). Despite these variations, all techniques achieved suc-
cessful recanalization (modified TICI ≥2b) in nearly 100% of 
the cases, according to the prior retrospective studies. In addi-
tion, first-pass modified TICI 3 recanalization was observed 
in between 43% to 72% of the patients, depending on the 
technique36-39,58). These results are encouraging, although still 
preliminary, for the development of innovative treatment 
strategies to benefit patients with acute LVO.
BALLOON GUIDE CATHETER IN CAT
Based on the results of five RCTs2,4,16,22,52), most stroke guide-
lines recommend endovascular treatment using SR-MT for 
acute LVO patients19,51,65). In real practice, however, two major 
frontline endovascular treatment methods, CAT and SR-MT, 
are currently used. In a recent survey of U.S. neurointeven-
tionalists, 39.7% of respondents reported using CAT as front-
line therapy followed by 28.2% opting for SR-MT, and 28.2% 
adopting for combined usage of a retrievable stent with aspira-
tion12). Moreover, the Contact Aspiration vs Stent Retriever for 
Successful Recanalization (ASTER) and COMPASS studies 
demonstrated that there were no significant differences in the 
rates of recanalization and good outcomes at 3 months be-
tween CAT and SR-MT32,61). Thus, proper designation of case-
dependent utilization of CAT versus SR-MT remains a chal-
lenge for future procedures.
BGC use has been recommended for SR-MT cases in previ-
ous RCTs, but not with CAT. Investigations regarding the role 
of BGC use in CAT are rare because the major group of CAT 
users (specifically ADAPT users) mostly use a 6 F neuro-
sheath as a guiding catheter, usually a Neuron Max (Penum-
bra)60,62). However, given the majority of CAT cases have sig-
nificant portions of clot outside the tip of the aspiration device 
(“corked” configuration), there is a risk of shearing the clot off 
of the aspiration device when entering the receiver, similar to 
that is occurred using the SR device. Recently, neurointerven-
tionalists have used the BGC and have reported positive re-
sults with BGC use during CAT. In one case series consisting 
of 31 patients with an acute anterior circulation stroke, the au-
thors proposed that the combination of two available methods 
for preventing distal clot migration, proximal f low arrest via 
use of a BGC and distal aspiration through a large bore cathe-
ter could improve the outcome of the thrombectomy proce-
dure57). The 8F Cello BGC (Medtronic) was used for the proxi-
mal flow control and the SOFIA catheter (Microvention) was 
used for the distal aspiration. Mechanical thrombectomy was 
performed under balloon occlusion of the proximal ICA and 
simultaneously with continuous distal aspiration, which re-
sulted in a 96.8% successful recanalization rate (modified 
TICI ≥2b), with good functional recovery (modified Rankin 
Scale 0–2 at 3 months) in 51.6% of cases.
In addition to the prevention of distal clot migration, recent 
reviews have suggested another positive effect of BGC use in 
mechanical thrombectomy28,66). Theoretically, two primary 
factors determine how much force will be required to retrieve 
the clot : the impaction force and the combined force of fric-
tion and adhesion between the thrombus and the vessel wall. 
The impaction force is determined by the pressure gradient 
across the thrombus (Fig. 3). Therefore, lower systemic blood 
pressure acting on the proximal surface of the thrombus and 
better retrograde collateral f low on the distal surface of the 
thrombus will result in a smaller pressure gradient across the 
occluding thrombus. Inflation of a BGC can markedly reduce 
the systemic blood pressure acting on the proximal clot face, 
leading to a decrease in the pressure gradient across the clot66). 
This can enhance the function of an aspiration catheter in 
CAT, as well as a stent retriever in SR-MT. The impaction 
force is also likely to explain the decreased rate of successful 
recanalization among patients with worse collaterals35).
A recent analysis compared data of the BGC and the CGC 
groups in frontline CAT cases using a Korean multi-center 
registry25). In the study, a total of 429 patients were enrolled, 
with the BGC used in 45.2% of patients. Compared to the 
CGC group, BGC use significantly reduced the number of 
CAT passes (mean, 2.6 vs. 3.4; p<0.001), puncture-to-recanali-
zation time (mean, 56 minutes vs. 64 minutes; p=0.018), and 
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embolization to distal or different site (0.5% vs. 3.4%, 
p=0.045). The BGC group showed significantly higher final 
(89.2% vs. 72.8%, p<0.001) and first-pass recanalization suc-
cess rates (24.2% vs. 8.1%, p<0.001). Those results were consis-
tent with previous clinical studies that involved frontline SR-
MT, which also reported the advantages of BGC, such as a 
decrease in distal embolization and an increase in the flow re-
versal effect.
To enhance the efficacy of CAT, there have been attempts to 
use early and active switching from CAT to SR-MT or to use a 
combination of CAT and SR-MT (incidence of switching : 
32% to 47.3%)26,27,33,58). For example, one study compared 119 
patients treated with frontline SR-MT to 124 patients treated 
with frontline CAT; when recanalization failed with the front-
line CAT, a large-bore aspiration catheter was used to intro-
duce a stent retriever33). Although the rate of successful recan-
alization by CAT only was 50.8% (63/124), rescue switching to 
SR-MT resulted in success in 69.6% of cases (39/56). As a re-
sult, frontline CAT group achieved a higher rate of final suc-
cessful revascularization as compared to SR-MT (82.3% vs. 
68.9%; p=0.022). However, the use of adjunctive devices was 
higher in the CAT group than in the SR-MT group (38.7% vs. 
13.3%; p<0.001). In the ASTER study, the first RCT to com-
pare frontline CAT and SR-MT, at least three attempts were 
required to be completed prior to switching to rescue thera-
py32). Although there was no significant difference in revascu-
larization rates (CAT, 85.4% vs. SR-MT, 83.1%; p=0.53) and 
rates of good functional recovery (modified Rankin Scale 0–2 
at 3 months; CAT, 45.3% vs. SR-MT, 50%; p=0.38), rescue 
therapy was more common in the CAT group than in the SR-
MT group (32% vs. 23.8%; odds ratio, 1.57; p=0.05). Consider-
ing the high rate of switching to SR-MT in frontline CAT pro-
cedures and the current recommendation of BGC use in SR-
MT, the BGC also seems a better option as a guiding catheter 
in CAT. However, whether to use the BGC during the CAT 
procedure remains controversial due to limited evidence. The 
positive results of the previous studies warrant a further pro-
spective study in a large population to compare the outcomes 
of use of the BGC and the CGC in frontline CAT procedures. 
OTHER APPLICATION OF BALLOON GUIDE 
CATHETER : REMOTE PROXIMAL ASPIRATION 
WITHOUT CLOT CONTACT
Despite the rapid evolution of endovascular devices and 
Psys
Fig. 3. Comparison of the pressure gradient (ΔP) across the clot between conventional guide catheters and balloon guide catheters in contact aspiration throm-
bectomy procedures. A : Contact aspiration under conventional guide catheter (CGC). ΔP = Psys + Pa – Pcol. B : Contact aspiration under balloon inflation of balloon 
guide catheter (BGC). ΔP = Pa - Pcol. MCA : middle cerebral artery, ICA : internal carotid artery.
A B
Pcol Pcol
ICA
Pa Pa
MCA M1 MCA M1
ΔP ΔP
clot clot
Pcol Pcol
CGC
ΔP = Psys + Pa - Pcol ΔP = Pa - Pcol
BGC
ICA
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techniques for recanalization of LVO, mechanical thrombec-
tomy still fails in about a quarter of cases2,4,16,22,52). Extensive 
burden of the occluding thrombus has been regarded as one 
of the main etiologies leading to complicated or failed throm-
bectomy procedures along with anatomical challenges, tan-
dem occlusions, and occlusions with underlying atherosclero-
sis29). A larger thrombus burden may complicate the 
endovascular procedure by requiring more passages with the 
thrombectomy device leading to a prolonged time to recanali-
zation. Such delays in recanalization can result in larger terri-
tory infarctions and a worse functional recovery. Additionally, 
more extensive thrombi may cause the occlusion of important 
collateral channels, as the original thrombus itself or migra-
tion of the thrombus may pervade noninvolved vascular terri-
tories. Off-label use of BGCs has been attempted to remove or 
reduce the LVO with extensive clot burden11,18,30,49). 
One such method involved remote aspiration through the 
BGC without any clot contact with a catheter or a stent re-
triever in distal ICA occlusions11). During remote aspiration, 
manual aspiration using a 60 mL syringe was performed 
through an 8 F BGC that was positioned in the cervical carotid 
vasculature to create proximal flow arrest (Fig. 4), resulting in 
a significant reduction of the clot burden, which facilitated 
further intervention leading to full recanalization. Thereafter, 
a few case reports describing similar BGC use followed18,49). 
Although the thrombectomy techniques were differently 
named in each report, such as ‘remote aspiration thrombecto-
my’ and ‘simple Aspiration with Balloon Catheter (ABC) 
technique’, the fundamentals of the techniques were very sim-
ilar. One study reported three cases of acute ICA occlusion 
treated with ‘remote aspiration thrombectomy’ which was di-
rect manual aspiration with a 60 mL syringe through a 9 F 
BGC in the cervical ICA and resulted in complete recanaliza-
tion. Another study reported two cases of cardioembolic ICA 
occlusion that were successfully treated with the ‘simple ABC 
technique’. This technique also involved simple manual aspi-
ration through an inflated 9 F BGC in the proximal ICA. All 
the above-mentioned studies demonstrated that the off-label 
use of the BGC proved useful in removing or reducing the clot 
burden and was a relatively safe and simple procedure. How-
ever, the interpretation of the results should be noted with 
caution since these technical case reports included a small 
number of patients. Other variables, such as clot consistency, 
vessel tortuosity, and the presence of a prominent posterior 
communicating artery, which can prevent adequate f low ar-
rest, may also determine the efficacy of the remote aspira-
tion11). 
A larger case series, which enrolled 86 ICA occlusion pa-
tients treated with mechanical thrombectomy during a 5-year 
period, compared the outcomes of endovascular strategies 
Fig. 4. Illustration of the off-label use of BGC to clot burden reduction in an intra¬cranial ICA T-type occlusion. Direct manual aspiration using a 60 mL 
syringe is performed through an 8 F or a 9 F BGC which was positioned in the proximal ICA to create proximal flow arrest. ACA : anterior cerebral artery, 
ICA : internal carotid artery, MCA : middle cerebral artery, BGC : balloon guide catheter.
ICA
MCAACA
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with or without the use of direct manual aspiration through a 
BGC at the cervical ICA30). Although in this series, the ma-
neuver was referred to as ‘proximal aspiration thrombectomy 
(PAT)’, but the technique was similar to the previously men-
tioned techniques. In phase 1 of the study, standard throm-
bectomy without PAT was used for removal of the ICA occlu-
sions (n=33). In phase 2, PAT was initially used, followed by 
the standard thrombectomy for any remaining occlusion 
(n=53). The authors defined ‘responders’ as patients who had 
part of the clot retrieved by PAT with partial or full recanali-
zation achieved. Fifteen of 53 patients (28.3%) in phase 2 re-
sponded to PAT and the responders had a significantly higher 
incidence of atrial fibrillation compared to non-responders 
(86.7% vs. 57.9%; p=0.046). The procedure time was signifi-
cantly reduced (94.5 minutes vs. 56.0 minutes; p=0.002) and 
the rate of successful reperfusion was improved (TICI ≥2b : 
45.5% vs. 73.6%; p=0.009) without increasing the incidence of 
procedure-related complications or intracranial hemorrhage. 
Overall, off-label use of a BGC seems to reduce clot burden in 
ICA occlusions. Further investigation in a larger patient co-
hort will be required to confirm the utility and safety of this 
approach.
CONCLUSION
With the rapid advancement of endovascular treatment 
therapy over time, varying thrombectomy techniques are be-
ing continuously fine-tuned to deliver the best possible func-
tional outcome for stroke patients. Key procedural features of 
the BGC include minimization of distal emboli as a result of 
antegrade f low control, increased rates of first-pass efficacy, 
and the ability to pair it with adjunctive devices to achieve 
successful reperfusion. In addition to allowing a shorter dura-
tion of intervention, the availability of crossover rescue with 
BGC as an alternative strategy for failure during CAT is criti-
cal for patients with LVO. As SR-MT and CAT are currently 
recognized as major frontline treatment methods, assessment 
of SR-MT with use of BGC has been correlated with clinically 
and angiographically favorable outcomes. However, limited 
evidence exists to prove significant benefit of BGC use in 
combination with distal aspiration. Further evaluation to ana-
lyze the role of BGC in CAT may be tested in the in-vitro sys-
tem of cerebrovascular occlusion, which is necessary to deter-
mine potential clinical usefulness of the technique. With the 
first-pass effect now considered the benchmark of successful 
thrombectomy, focus of future study should aim to explore 
the capability of BGCs to lower the rate of adverse events, 
maximize the number of TICI 3 cases, and reduce the number 
of thrombectomy attempts during clot retrieval.
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